Correction to: A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL

The blots of control and docetaxel for caspase-9, caspase-3, caspase-8, Bcl- XL , and tubulin in the Figure 4f were reused from Figure 4 of our previous paper published in Journal of Urology in 2010 ( https://doi.org/10.1016/j.juro.2010.07.035 ).

Saved in:
Bibliographic Details
Published inInvestigational new drugs Vol. 37; no. 4; p. 796
Main Authors Hwang, Jung Jin, Kim, Yong Sook, Kim, Taelim, Kim, Mi Joung, Jeong, In Gab, Lee, Je-Hwan, Choi, Jene, Jang, Sejin, Ro, Seonggu, Kim, Choung-Soo
Format Journal Article
LanguageEnglish
Published New York Springer US 15.08.2019
Springer Nature B.V
Subjects
Correction
Medicine
Medicine & Public Health
Oncology
Pharmacology/Toxicology
Online AccessGet full text

Cover

More Information
Summary:The blots of control and docetaxel for caspase-9, caspase-3, caspase-8, Bcl- XL , and tubulin in the Figure 4f were reused from Figure 4 of our previous paper published in Journal of Urology in 2010 ( https://doi.org/10.1016/j.juro.2010.07.035 ).
Bibliography:correction
SourceType-Other Sources-1
content type line 63
ObjectType-Correction/Retraction-1
ISSN:0167-6997
1573-0646
DOI:10.1007/s10637-019-00746-y